Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,127 | 609 | 99.5% |
| Education | $39.08 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,318 | 46 | $0 (2021) |
| Allergan, Inc. | $500.43 | 46 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $470.10 | 34 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $468.71 | 57 | $0 (2021) |
| GlaxoSmithKline, LLC. | $415.51 | 37 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $385.69 | 16 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $321.12 | 38 | $0 (2021) |
| CSL Behring | $274.75 | 20 | $0 (2021) |
| Genentech USA, Inc. | $265.87 | 18 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $247.38 | 48 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $77.05 | 3 | Genmab U.S., Inc. ($42.76) |
| 2021 | $1,424 | 115 | Biohaven Pharmaceuticals, Inc. ($443.93) |
| 2020 | $2,201 | 155 | AstraZeneca Pharmaceuticals LP ($342.88) |
| 2019 | $1,719 | 126 | AstraZeneca Pharmaceuticals LP ($318.33) |
| 2018 | $1,479 | 131 | AstraZeneca Pharmaceuticals LP ($302.88) |
| 2017 | $1,266 | 83 | AstraZeneca Pharmaceuticals LP ($197.46) |
All Payment Transactions
613 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Oncology | ||||||
| 07/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $103.92 | General |
| Category: NEUROSCIENCE | ||||||
| 05/27/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: PRIMARY CARE | ||||||
| 05/25/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: PRIMARY CARE | ||||||
| 05/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: PRIMARY CARE | ||||||
| 05/19/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: PRIMARY CARE | ||||||
| 05/18/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: PRIMARY CARE | ||||||
| 05/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: PRIMARY CARE | ||||||
| 05/12/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: PRIMARY CARE | ||||||
| 05/11/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: PRIMARY CARE | ||||||
| 05/07/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: PRIMARY CARE | ||||||
| 05/06/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Neuroscience | ||||||
| 05/06/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: PRIMARY CARE | ||||||
| 05/04/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/04/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: PRIMARY CARE | ||||||
| 05/03/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Immunology | ||||||
| 04/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 43 | 3,333 | 8,758 | $270,308 | $118,313 |
| 2020 | 61 | 5,543 | 20,738 | $356,601 | $265,747 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 334 | 621 | $115,275 | $50,785 | 44.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 89 | 157 | $17,909 | $8,186 | 45.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 150 | 231 | $17,115 | $7,624 | 44.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 127 | $16,200 | $6,764 | 41.8% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2021 | 62 | 92 | $5,340 | $3,508 | 65.7% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 27 | 310 | $6,288 | $3,294 | 52.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 192 | 313 | $8,784 | $3,251 | 37.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 206 | 350 | $4,756 | $2,670 | 56.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 113 | 130 | $4,551 | $2,407 | 52.9% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 86 | 177 | $5,877 | $2,267 | 38.6% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 41 | 52 | $8,181 | $2,244 | 27.4% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 73 | 88 | $5,683 | $2,028 | 35.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 14 | $3,745 | $1,769 | 47.2% |
| 70220 | X-ray of paranasal sinus, complete, minimum of 3 views | Office | 2021 | 63 | 70 | $5,097 | $1,615 | 31.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 172 | 1,726 | $3,647 | $1,598 | 43.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 96 | 132 | $3,960 | $1,379 | 34.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 86 | 97 | $2,325 | $1,272 | 54.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 67 | 73 | $1,604 | $1,226 | 76.5% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 55 | 205 | $3,445 | $1,204 | 35.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 222 | 403 | $1,697 | $1,201 | 70.8% |
| 83874 | Myoglobin (muscle protein) level | Office | 2021 | 63 | 93 | $1,987 | $1,169 | 58.8% |
| 84484 | Troponin (protein) analysis, quantitative | Office | 2021 | 63 | 93 | $1,649 | $1,127 | 68.4% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2021 | 85 | 141 | $1,968 | $1,077 | 54.7% |
| 82553 | Creatine kinase (cardiac enzyme) level, mb fraction only | Office | 2021 | 63 | 93 | $1,780 | $1,045 | 58.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 18 | 20 | $1,520 | $1,026 | 67.5% |
About Dr. David Wright, M.D
Dr. David Wright, M.D is a Allergy & Immunology healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902857717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Wright, M.D has received a total of $8,166 in payments from pharmaceutical and medical device companies, with $77.05 received in 2024. These payments were reported across 613 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($8,127).
As a Medicare-enrolled provider, Wright has provided services to 8,876 Medicare beneficiaries, totaling 29,496 services with total Medicare billing of $384,060. Data is available for 2 years (2020–2021), covering 105 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Springfield, IL
- Active Since 05/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RA0201X
- Entity Type Individual
- NPI Number 1902857717
Products in Payments
- NURTEC ODT (Drug) $468.71
- SYMBICORT (Drug) $420.33
- BEVESPI AEROSPHERE (Drug) $339.27
- UBRELVY (Drug) $308.04
- TRELEGY ELLIPTA (Drug) $255.89
- DUPIXENT (Biological) $255.07
- FARXIGA (Drug) $231.31
- Hizentra (Biological) $227.20
- Xhance (Drug) $223.71
- Dayvigo (Drug) $217.86
- Xyrem (Drug) $209.78
- Arikayce (Drug) $207.68
- TROKENDI XR (Drug) $189.80
- Aimovig (Biological) $182.64
- PROAIR (Drug) $172.66
- STIOLTO RESPIMAT (Drug) $166.14
- VRAYLAR (Drug) $162.21
- XYREM (Drug) $155.23
- STIOLTO (Drug) $143.62
- FASENRA (Drug) $141.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Springfield
Oral Alpan, Md, MD
Allergy & Immunology — Payments: $142,085
Minh-Thu Le, Md, MD
Allergy & Immunology — Payments: $17,183
Satyen Gada, Md, MD
Allergy & Immunology — Payments: $11,422
Dr. Gregory Lux, Md, MD
Allergy & Immunology — Payments: $6,730
Dr. Sudha Prasad, M.d.c.s, M.D.C.S
Allergy & Immunology — Payments: $2,556
Dr. Nancy Deangelis Currey, Md, MD
Allergy & Immunology — Payments: $1,950